Zobrazeno 1 - 10
of 215
pro vyhledávání: '"Donald P, Lawrence"'
Autor:
Mariano Severgnini, Rizwan Haq, Anita Giobbie-Hurder, Scott J Rodig, Patrick A Ott, Evisa Gjini, Ryan J Sullivan, Donald P Lawrence, Matthew Nazzaro, Kathleen L Pfaff, Jacquelyn O Wolff, Elizabeth I Buchbinder
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 11 (2021)
Externí odkaz:
https://doaj.org/article/209a1d9fbce1433f83f364f311d116e0
Autor:
Meghan J. Mooradian, James M. Cleary, Anita Giobbie‐Hurder, Lancia N. F. Darville, Aparna Parikh, Elizabeth I. Buchbinder, Justine V. Cohen, Donald P. Lawrence, Geoffrey I. Shapiro, Harold Keer, Helen X. Chen, Susan Percy Ivy, Keiran S. M. Smalley, John M. Koomen, Ryan J. Sullivan
Publikováno v:
Cancer. 129:1904-1918
Autor:
F Stephen Hodi, Ahmad A Tarhini, John M Kirkwood, Zeynep Eroglu, Henry B Koon, Ni Kang, Vernon K Sondak, Harriet M Kluger, Sandra J Lee, Gary I Cohen, Laura F Hutchins, Donald P Lawrence, Kari L Kendra, David R Minor, Carrie B Lee, Mark R Albertini, Lawrence E Flaherty, Teresa M Petrella
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Background The impact of immune-related adverse events (irAEs) occurring from adjuvant use of immunotherapy and of their management on relapse-free survival (RFS) and overall survival (OS) outcomes is currently not well understood.Patients and method
Externí odkaz:
https://doaj.org/article/6f596cfb2e7048f7b2e60a6a21991735
Publikováno v:
Frontiers in Physiology, Vol 11 (2020)
Natural Killer Lytic-Associated Molecule (NKLAM), also designated RNF19B, is a unique member of a small family of E3 ubiquitin ligases. This 14-member group of ligases has a characteristic cysteine-rich RING-IBR-RING (RBR) domain that mediates the ub
Externí odkaz:
https://doaj.org/article/511b4ecb04db4123b4f61d341f6604ec
Autor:
Moshe Sade-Feldman, Yunxin J. Jiao, Jonathan H. Chen, Michael S. Rooney, Michal Barzily-Rokni, Jean-Pierre Eliane, Stacey L. Bjorgaard, Marc R. Hammond, Hans Vitzthum, Shauna M. Blackmon, Dennie T. Frederick, Mehlika Hazar-Rethinam, Brandon A. Nadres, Emily E. Van Seventer, Sachet A. Shukla, Keren Yizhak, John P. Ray, Daniel Rosebrock, Dimitri Livitz, Viktor Adalsteinsson, Gad Getz, Lyn M. Duncan, Bo Li, Ryan B. Corcoran, Donald P. Lawrence, Anat Stemmer-Rachamimov, Genevieve M. Boland, Dan A. Landau, Keith T. Flaherty, Ryan J. Sullivan, Nir Hacohen
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-11 (2017)
Resistance to immune-checkpoint blockade often occurs in treated patients. Here, the authors demonstrate that B2M loss is a mechanism of primary and acquired resistance to therapies targeting CTLA4 or PD-1 in melanoma patients.
Externí odkaz:
https://doaj.org/article/4b7fd694a84645dbafce545e168de8d2
Autor:
Xue Bai, Alexander N. Shoushtari, Allison Betof Warner, Lu Si, Bixia Tang, Chuanliang Cui, Xiaoling Yang, Xiaoting Wei, Henry T. Quach, Christopher G. Cann, Michael Z. Zhang, Lalit Pallan, Catriona Harvey, Michelle S. Kim, Gyulnara Kasumova, Tatyana Sharova, Justine V. Cohen, Donald P. Lawrence, Christine Freedman, Riley M. Fadden, Krista M. Rubin, Dennie T. Frederick, Keith T. Flaherty, Georgina V. Long, Alexander M. Menzies, Ryan J. Sullivan, Genevieve M. Boland, Douglas B. Johnson, Jun Guo
Publikováno v:
British Journal of Dermatology. 187:401-410
Background Programmed cell death receptor-1 (PD-1) monotherapy is a standard treatment for advanced cutaneous melanoma, but its efficacy and toxicity are defined in white populations and remain poorly characterized in other ethnic groups, such as Eas
Autor:
Justine V. Cohen, Doll Lauren Alexandra Golden, Syed S. Mahmood, Raza M. Alvi, Nathaniel D. Mercaldo, Malek Z. O. Hassan, Adam Rokicki, Connor Mulligan, Sean P. T. Murphy, Maeve Jones-O’Connor, Lucie M. Heinzerling, Rongras Damrongwatanasuk, Carol L. Chen, Michael C. Kirchberger, Sachin P. Shah, Muhammad A. Rizvi, Carlo G. Tocchetti, Valentina Mercurio, Donald P. Lawrence, John D. Groarke, Michael G. Fradley, Kerry L. Reynolds, Tomas G. Neilan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1 (2019)
BackgroundInfluenza vaccination (FV) is recommended for patients with cancer. Recent data suggested that the administration of the FV was associated with an increase in immune-related adverse events (irAEs) among patients on immune checkpoint inhibit
Externí odkaz:
https://doaj.org/article/23d13b13f69045c4aed81f89294aab8e
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222802 (2019)
Recent studies have begun to elucidate a role for E3 ubiquitin ligases as important mediators of the innate immune response. Our previous work defined a role for the ubiquitin ligase natural killer lytic-associated molecule (NKLAM/RNF19b) in mouse an
Externí odkaz:
https://doaj.org/article/94433615d9d644038605e414295c940a
Autor:
Levi A. Garraway, Jennifer A. Wargo, Keith T. Flaherty, Scott L. Carter, Stacey B. Gabriel, Gad Getz, Sheila Fisher, Donald P. Lawrence, Eran Hodis, Gregory Kryukov, Kristian Cibulskis, Aaron McKenna, Cory M. Johannessen, Danielle Perrin, Kristin Anderka, Dennis C. Friedrich, Deborah N. Farlow, Ryan J. Sullivan, Eva M. Goetz, Mara Rosenberg, Amaro Taylor-Weiner, Zachary A. Cooper, Dennie T. Frederick, Daniel J. Treacy, Eliezer M. Van Allen, Nikhil Wagle
XLSX file 3569K, Change in Cancer Cell Fraction for all SNVs and Indels in All Samples
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2deea5c2c969e4a862f7cb47d2a497f3
https://doi.org/10.1158/2159-8290.22530000
https://doi.org/10.1158/2159-8290.22530000
Autor:
Levi A. Garraway, Jennifer A. Wargo, Keith T. Flaherty, Scott L. Carter, Stacey B. Gabriel, Gad Getz, Sheila Fisher, Donald P. Lawrence, Eran Hodis, Gregory Kryukov, Kristian Cibulskis, Aaron McKenna, Cory M. Johannessen, Danielle Perrin, Kristin Anderka, Dennis C. Friedrich, Deborah N. Farlow, Ryan J. Sullivan, Eva M. Goetz, Mara Rosenberg, Amaro Taylor-Weiner, Zachary A. Cooper, Dennie T. Frederick, Daniel J. Treacy, Eliezer M. Van Allen, Nikhil Wagle
XLSX file 31K, Coverage and Metrics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28bdf7aa0f8c302cf82e86bc6c35fda4
https://doi.org/10.1158/2159-8290.22529985
https://doi.org/10.1158/2159-8290.22529985